The Use of Interferons in Respiratory Viral Infections

作者: Geoff Scott

DOI: 10.1007/978-94-011-7930-0_20

关键词:

摘要: It was at the National Institute of Medical Research, Mill Hill, in 1956–1957 when Alec Isaacs, with his postgraduate student Jean Lindenmann, made their profound discovery interferon. Viral interference had been recognized for many years. Indeed, Edward Jenner observed that vaccination cowpox sometimes did not ’take’ a subject herpes infection. Definitive animal experiments illustrating phenomenon were first reported 1935 and by 1950, Henle [33] wrote an extensive review on subject. While investigating viral influenza viruses 1957, Isaacs Lindenmann [43,44] showed fragments chick chorioallantoic membrane secreted substance into tissue culture supernatant response to killed virus which able protect fresh pieces against live challenge. This identified as non-dialysable protein molecular weight around 20 000 Da, resistant pH 2. Recognizing produced cells could other genius this experiment but second brilliant move give its name: ’interferon’. Legend has it name suggested during afternoon tea while discussing results colleagues. The catchy, papers clear straight forward implications exciting enough catch public’s imagination be discussed lay press. Because scientists initially suspicious results, also named ‘misinterpreton’ time. However, over number years, more groups found interferon activity different cell-virus systems then animals infection, fact became inescapable.

参考文章(61)
V. D. Solov'ev, The results of controlled observations on the prophylaxis of influenza with interferon. Bulletin of The World Health Organization. ,vol. 41, pp. 683- 688 ,(1969)
T Karaki, S Isomura, A Matsuo, M Shibata, T Ichikawa, H Naruse, J Imanishi, M Miyazu, T Kishida, The preventive effect of human interferon-alpha on influenza infection; modification of clinical manifestations of influenza in children in a closed community. Biken's Journal. ,vol. 25, pp. 131- 137 ,(1982)
R. Berger, M. Just, O. Ruuskanen, M. Lüdin, S. N. Linder-Ciccolunghi, Early Treatment of the Common Cold with Intranasal Interferon Alpha-2a (Ro 22–8181): A Preliminary Pilot Study The Biology of the Interferon System 1986. pp. 443- 448 ,(1987) , 10.1007/978-94-009-3543-3_60
Werner Henle, Interference Phenomena Between Animal Viruses: A Review Journal of Immunology. ,vol. 64, pp. 203- 236 ,(1950)
Paul E. Johnson, Stephen B. Greenberg, Bobby R. Alford, Robert B. Couch, Maurice W. Harmon, Recovery of Applied Human Leukocyte Interferon from the Nasal Mucosa of Chimpanzees and Humans Journal of Clinical Microbiology. ,vol. 4, pp. 106- 107 ,(1976) , 10.1128/JCM.4.1.106-107.1976
M W Harmon, S B Greenberg, P E Johnson, R B Couch, Human nasal epithelial cell culture system: evaluation of response to human interferons. Infection and Immunity. ,vol. 16, pp. 480- 485 ,(1977) , 10.1128/IAI.16.2.480-485.1977
P G Higgins, R J Phillpotts, G M Scott, J Wallace, L L Bernhardt, D A Tyrrell, Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers. Antimicrobial Agents and Chemotherapy. ,vol. 24, pp. 713- 715 ,(1983) , 10.1128/AAC.24.5.713
John K. Petralli, Thomas C. Merigan, Jordan R. Wilbur, Circulating Interferon after Measles Vaccination The New England Journal of Medicine. ,vol. 273, pp. 198- 201 ,(1965) , 10.1056/NEJM196507222730405
R.J. Phillpotts, G.M. Scott, P.G. Higgins, J. Wallace, D.A.J. Tyrrell, C.L. Gauci, An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-α2 Antiviral Research. ,vol. 3, pp. 121- 136 ,(1983) , 10.1016/0166-3542(83)90034-7
Samuel Baron, Stephen K Tyring, W Robert Fleischmann, Dorian H Coppenhaver, David W Niesel, Gary R Klimpel, G John Stanton, Thomas K Hughes, The interferons. Mechanisms of action and clinical applications JAMA: The Journal of the American Medical Association. ,vol. 266, pp. 1375- 1383 ,(1991) , 10.1001/JAMA.266.10.1375